K. Wollschlaeger

Klinikum Magdeburg, University Hospital Magdeburg

Papers

3

Total Citations

123

H-Index

3

About

Dr. K. Wollschlaeger is a leading gynecologic oncologist whose research has fundamentally shaped the understanding and clinical management of borderline ovarian tumors (BOT). Her work focuses on the critical interplay between patient age, surgical staging, and long-term prognosis in this rare ovarian malignancy. Dr. Wollschlaeger’s major contributions stem from her central role in the large-scale, multicenter AGO ROBOT study, a landmark pattern-of-care investigation that included central pathology review. Her most cited paper (75 citations) revealed age-dependent differences in BOT, demonstrating that younger patients exhibit distinct clinical characteristics and more favorable outcomes. A subsequent influential study (42 citations) provided crucial evidence that incomplete surgical staging is a negative prognostic factor, systematically analyzing the impact of each individual staging procedure to guide surgical decision-making. Through these high-impact works, Dr. Wollschlaeger has established evidence-based standards for the surgical management of BOT, directly improving risk stratification and treatment planning for patients worldwide.

Research Focus

Key Achievements

3
H-Index
3
Papers
123
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study
75 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: Klinikum Magdeburg, University Hospital Magdeburg

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago